NANO MRNA Co.,Ltd. (4571.T) JPX
137.00
-1(-0.72%)
Currency In JPY
- General
- Statistics
- Historical Data
- Profile
- Financials
137.00
-1(-0.72%)
Currency In JPY
Address
Onoya-Kyobashi Building
Tokyo, 104-0031
Japan
Phone
81 3 3241 0550
Website
Sector
Healthcare
Industry
Biotechnology
Employees
18
First IPO Date
March 05, 2008
| Name | Title | Pay | Year Born |
| Shiro Akinaga | President, Chief Executive Officer & Representative Director | 0 | 1956 |
| Atsushi Matsumura | Executive Chairperson of the Board | 0 | 1962 |
| Koji Fujimoto | Executive Officer & Chief Financial Officer | 0 | 1972 |
NANO MRNA Co., Ltd. engages in the research, development, and production of pharmaceuticals using micellar nanoparticles technology. The company develops biopharmaceutical products focused on the medication of cancer and other intractable diseases. It also engages in the research, development, manufacture, and sale of anti-cancer drugs based on micellar nanoparticle technology. The company was founded by Kazunori Kataoka, Teruo Okano, and Ichiro Nakatomi on June 14, 1996 and is headquartered in Tokyo, Japan.